The GMiP

Ganoderma microsporum immunomodulatory protein was developed under the leadership of NTU professor Dr. R.S. Hseu, who has been the pursuit of unlocking the true potential of GMiP and has persisted for the last 40 years. ITCAN cooperated with industry-leading professors and doctors from the micro immunology institutes many research paper was published during its development.

GMiP holds many global patents ranging from treatments for different types of cancer, including lung cancer, liver cancer, and colorectal cancer to proven effects of wound healing. Immunomodulatory protein forging a new vision in biomedicine. The Reishimmune® is an all-new biotech ingredient utilized in the fields of precision medicine, nutritional health, cosmetic medicine, animal healthcare, and more.

ITCAN provides CDMO and OEM services the production facility has obtained ISO 22000 and HACCP meets international quality certification. Health products meet the requirements of GRAS with approval from FDA USA and Taiwan. According to the requirements, ITCAN provides a one-stop service from market research to the end product to the customer.